Loading song details...
Dr Robert Motzer Reviews The Phase III COMPARZ Study
No description available.
MP3 Download
Video Download
Related Songs
2:32
Dr Robert Motzer Discusses The Safety And Efficacy Of Tivozanib In Kidney Cancer
2:33
Dr Robert Motzer Reviews The TIVO 1 Study Survival Findings
6:19
ASCO GU 2013 TIVO 1 Study Shows Tivozanib An Option For Renal Cell Carcinoma Dr Robert Motzer
5:50
Phase II Trial On Nivolumab In MRCC Dr Robert Motzer At ASCO 2014
1:39
Robert J Motzer M D Receives Schonfeld Award From Kidney Cancer Association
5:46
TIVO 1 Phase 3 Study In Advanced Kidney Cancer
2:25
Dr Motzer On A Phase II Trial Of Nivolumab For MRCC
3:55
Drugs For Metastatic Kidney Cancer Offer Similar Survival
1:25
Dr Motzer Discusses Nivolumab For MRCC
1:57
Dr Motzer On Nivolumab Versus Everolimus In Renal Call Carcinoma
1:08
Dr Motzer On Nivolumab Ipilimumab Activity In RCC
1:24
Dr Motzer On The TIVO 1 Trial With Tivozanib In Advanced RCC
1:11
Dr Motzer On The Milestone Of Immunotherapy In RCC
1:07
Robert J Motzer MD Elaborates On Key Findings From The Phase III CLEAR Trial
1:28
Dr Motzer On The TIVO 3 Trial Examining Tivozanib In Advanced RCC
1:10
Dr Motzer On First Line Treatment Of Metastatic RCC
1:49
Robert J Motzer MD Speculates On The Future Role Of Combination Therapy In Advanced CcRCC
15:16
Community Clinic Translating Data Into Action Practical Strategies For Optimizing First Line R
9:23
JAVELIN Renal 101 Avelumab Plus Axitinib Improve PFS For Advanced Cell Cancer
4:07